ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM Immupharma Plc

2.14
0.00 (0.00%)
Last Updated: 09:35:12
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.14 2.10 2.19 - 219,181 09:35:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.88 7.13M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.14p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7.13 million. Immupharma has a price to earnings ratio (PE ratio) of -1.88.

Immupharma Share Discussion Threads

Showing 32801 to 32816 of 39125 messages
Chat Pages: Latest  1313  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  Older
DateSubjectAuthorDiscuss
05/7/2018
10:06
Better off in (AOR)imho, strong management, great little company , still only 60p’s but broker sets 400p price target, which should be achievable inside 2 yrs, i’ll drink to that!
ny boy
05/7/2018
10:02
Nobby, shout the winners from the rooftops and brush the losers under the carpet eh - all hail the King of I AM....lol
watchman50
05/7/2018
09:43
>>watchman

Many apologies for tipping a share (SNG) which went up 100% in just over a week 🤔...... I think most people would be happy with that but apparently not you!

nobbygnome
05/7/2018
09:29
Nobby, bit quick to jump in there and incorrectly accept the plaudit from Glenn that you were being hailed as the king of AIM - slightly narcissistic tendencies showing through I believe, must be why you feel the need to regularly ramp your holdings in other AIM companies on this thread....lol

Anyway, trying to get the discussion back on to the subject of the lack of new information we are experiencing with IMM at present which is clearly keeping the share price around the enterprise value, and barring the possible announcement of a deal with a large pharma which IMHO will not be coming just yet, I'm guessing the next news milestone we will get is the full results & analysis from the P3 trial.

If I recall correctly a lot of 'industry insiders' were saying this would likely be 3 months or so after the headline results - if so how likely do people think this is likely to come sometime towards the end of July? Could this provide a catalyst for a bit of a price increase if any new positives come to light and if so what are those positives likely to be

Also when do folk think we are likely to get some update regarding progress of those on the open label follow-on trial? Wouldn't it just be fantastic if those taking part continued to see a benefit to their condition, have been able to reduce their use of some of the SOC nasties & maybe an odd remission or two. Realise this is probably 3 to 6 months away but how do we think that would effect the likelihood of a partnership deal & the share price?

watchman50
05/7/2018
08:56
I can now choose any gender that l want to be
abbotslynn
05/7/2018
08:54
Not any moreMan today Woman tomorrow who knows
abbotslynn
04/7/2018
16:26
Oh I see. I hope I know who I am....if not I am in trouble....
nobbygnome
04/7/2018
15:55
Hi Nobby more subtle..I Am.... you know who you are...
glennrcharles
04/7/2018
15:22
Careful Glenn, Brad will be accusing you of being me 😜

I presume you mean AIM not IAM and if so, thanks for the complement!

Nobby

nobbygnome
04/7/2018
15:04
Whilst Nobby's expertise on IMM might sometimes be questioned, I believe that his expertise on IAM is unrivalled. I tend to believe him.
glennrcharles
04/7/2018
12:17
Moving up again, this could be the start of the recovery as it's well overdue.
deltalo
04/7/2018
11:05
Well the 'proven efficacy' statement in the Proactive interview is a classic......
nobbygnome
04/7/2018
09:04
you are on filter knowitallgnome, who are you going to be later on? man of many monikers?
brad44
04/7/2018
08:57
>> Brad

Talking about broken records, it takes one to know one....

nobbygnome
04/7/2018
08:54
chance of full remission, little or no chance of death..MASSIVE ADVANTAGE

-IT IS A SMALL PEPTIDE, NOT A MONOCLONAL ANTIBODY


-CONVENIENT DOSING; ONLY A SMALL QUANTITY NEEDED EVERY FEW WEEKS


-GOOD SAFETY PROFILE


-GOOD EFICACY AS SHOWN IN

CLINICAL TRIALS
he key highlights and advantages of Lupuzor™ include:

—UNIQUE MECHANISM OF ACTION -

—MODULATES THE IMMUNE SYSTEM TO CORRECT ITS ABNORMALITY

—IT IS A SMALL PEPTIDE, NOT A MONOCLONAL ANTIBODY

—CONVENIENT DOSING; ONLY A SMALL QUANTITY NEEDED EVERY FEW WEEKS

—GOOD SAFETY PROFILE

—GOOD EFICACY AS SHOWN IN CLINICAL TRIALS

brad44
04/7/2018
08:51
che7win
11 Apr '18 - 08:03 - 24751 of 32795
0 4 1
From an American poster on LSE:

I messaged Barbie Lupus through FB in february to see what her experience of Lupuzor was . Never received a reply until 0411am, when she said the following.
It was amazing. I was devastated when my clinical trial was cut. All my symptoms improved...hair loss, fatigue, mouth, eye and nose ulcers, I was only taking plaquenil and the Lupuzor injection. It was after my trial was cut that I really took a turn downhill. Everything went SOUTH!!! Lupuzor is incredible and I pray it gets FDA approval. I have so many lupie friends that I know it would benefit. Just sad we have to we all have to wait so long :
Not sure why she took so long to reply, but seems very strange just before p3 results are going to be released?
Barbie Manchester

Woman, Barbie Manchester from North Carolina, with terminal Lupus took Lupuzor, with the result she didn't know she was ill during that time. Since then she has had other treatments none of which gave the benefits of lupuzor:



The drug administered in her first trial, Lupuzor, worked well. But after three years, the trial ended. “That was very devastating,” she said. “For me personally, that was the best medication. You’d never have known I was sick.”


Melanie Regnaud

Young woman, Melanie Regnaud, a longstanding lupus sufferer took Lupuzor & gets better. Now leading a normal life & has her first ever boyfriend:

May 2017 article -


"For 13 years, she experienced physical suffering, mental exhaustion...She has lupus; the same illness of which his aunt has died...She is always sick, she can not go to school, she finds herself admitted to the clinic almost every two weeks...
...Melanie started a new job at the beginning of the year, she has a boyfriend and a family who adores her. Since she started a new treatment, Lupuzor, she is doing better. She only takes 5 mg of corticosteroids and always goes on medical appointments every three months... 'If you told me, six or seven years ago, that in 2017, I would meet a man who loves me, that I was going to work, that I would be alive and that I would be better, I would not have believed you! ' ...Incredible but true. What a beautiful course."

brad44
Chat Pages: Latest  1313  1312  1311  1310  1309  1308  1307  1306  1305  1304  1303  1302  Older

Your Recent History

Delayed Upgrade Clock